Table 1.
Patient characteristics at living donor liver transplantation.
| Non-RI group (n = 41) | RI group (n = 19) | P value | |
|---|---|---|---|
| (eGFR (mL/min/1.73 m2)) | (94.8 ± 26.9) | (42.5 ± 15.9) | |
| Age at LT (years) | 49.2 ± 11.5 | 52.9 ± 9.0 | 0.23 |
| Male sex—n (%) | 21 (51.2) | 13 (68.4) | 0.21 |
| Primary diagnosis—n (%) | 0.63 | ||
| HBV | 15 (36.6) | 9 (47.4) | |
| Alcoholic | 8 (19.5) | 5 (26.3) | |
| AIH | 4 (9.8) | 1 (5.3) | |
| Others | 14 (34.1) | 4 (21.1) | |
| MELD | 16.5 ± 7.1 | 24.7 ± 10.7 | < 0.01 |
| eGFR at 1st year after LT (mL/min/1.73 m2) | 77.2 ± 28.2 | 60.1 ± 13.5 | < 0.01 |
| eGFR > 60 at 1st year after LT—n (%) | 26 (72.2) | 10 (58.8) | 0.33 |
| AR within 1st year—n (%) | 10 (24.4) | 5 (26.3) | 0.87 |
| Bacterial infections—n (%) | 13 (31.7) | 8 (42.1) | 0.43 |
| Fungal infections—n (%) | 4 (9.8) | 4 (21.1) | 0.23 |
| CMV infections—n (%) | 10 (24.4) | 7 (36.8) | 0.32 |
RI, renal insufficiency; LT, liver transplantation; HBV, hepatitis B virus; AIH, Autoimmune hepatitis; eGFR, estimated glomerular filtration rate; MELD, model for end-stage liver disease; AR, acute rejection; CMV, cytomegalovirus. Data are expressed as means ± standard deviation. Difference with P < 0.05 was considered significant.